The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.
In recent years, investigators have readdressed the complex issues involved in the classification of inflammatory bowel diseases. In 2003, a Working Party of investigators with an interest in the issues involved in disease subclassification was formed with the aim of summarising recent developments in disease classification and establishing an integrated clinical, molecular, and serological classification of inflammatory bowel disease. The results of the Working Party were reported at the 2005 Montreal World Congress of Gastroenterology. Here we highlight the key issues that have emerged from discussions of the Montreal Working Party and the relevance to clinical practice and research activities.
Satsangi
J
J
Gstrointestinal Unit, Western General Hospital, University of Edinburg, UK.
Silverberg
M S
MS
Vermeire
S
S
Colombel
J-F
JF
D015415:Biomarkers / Q000097:blood; D003092:Colitis / Q000145:classification; D003093:Colitis, Ulcerative / Q000145:classification; D003424:Crohn Disease / Q000145:classification; D005819:Genetic Markers; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000145:classification*
D015415:Biomarkers; D005819:Genetic Markers